An increased ratio of CD14+HLA-DRlo inflammatory monocytes to tissue-resident alveolar macrophages has also been noted (18), and macrophage hyperactivation by persistent IFN-γ production previously has been suggested to be a possible mechanism in COVID-19 (38). This evidence concerns the gene CD14 and COVID-19.